GNI Group

2160.TTSE GROWTHPharmaceutical

Filed as GNI Group Ltd. (2022-08–2026-08)

Key numbers · FY ended 2025-12

Revenue¥26.8bn+13.7% YoY Operating income−¥3.5bn-347.6% YoY Net income (owners)−¥4.2bn-486.5% YoY Total assets¥83.8bn+16.5% YoY EPS (basic)¥-80.9-468.4% YoY

Full financial history and reports →

Stock price2160 · View chart ↗

Open the price chart on TradingView.

Latest filings

Wed, Nov 4 · JST1 filing

10:335% STAKEGNI Group · BCP Asia AYM Holding (Cayman) L.P. · 10.61% → 4.97%−5.64pp

Tue, Aug 25 · JST1 filing

09:37MATERIALGNI Group · Change in major shareholder

Mon, Jul 6 · JST1 filing

14:445% STAKEGNI Group · BCP Asia AYM Holding (Cayman) L.P. · 10.61%new 10.61%

Wed, Jul 1 · JST1 filing

16:00MATERIALGNI Group · Change in major shareholder

Fri, Jun 5 · JST1 filing

15:30MATERIALGNI Group · Change in parent company or specified subsidiary

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Ying Luo	7.81%	—	2025-07-31

Each holder's own ratio from its most recent large-shareholding report.